Phase II study of neoadjuvant weekly nab-paclitaxel and carboplatin, with bevacizumab and trastuzumab, as treatment for women with locally advanced HER2+ breast cancer. (Q54576533)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase II study of neoadjuvant weekly nab-paclitaxel and carboplatin, with bevacizumab and trastuzumab, as treatment for women with locally advanced HER2+ breast cancer. |
scientific article |
Statements
Phase II study of neoadjuvant weekly nab-paclitaxel and carboplatin, with bevacizumab and trastuzumab, as treatment for women with locally advanced HER2+ breast cancer. (English)
John D Hainsworth
1 reference
Denise A Yardley
Eric Raefsky
Raul Castillo
Anup Lahiry
Richard Locicero
Dana Thompson
Mythili Shastry
Howard A Burris
5 May 2011
11
5
297-305